These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6817483)

  • 1. Immunological studies with sulpholipids of mycobacteria.
    Khuller GK; Malik U; Subrahmanyam D
    Tubercle; 1982 Jun; 63(2):107-11. PubMed ID: 6817483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specific antisera to mycobacteria].
    Makarova MV; Kalinina OA; Murzakhmetova ZE; Chernousova LN; Litvinov VI
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):3-6. PubMed ID: 8067139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactions between mycobacteria. II. Crossed immunoelectrophoretic analysis of soluble antigens of BCG and comparison with other mycobacteria.
    Harboe M; Mshana RN; Closs O; Kronvall G; Axelsen NH
    Scand J Immunol; 1979; 9(2):115-24. PubMed ID: 106465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and partial characterization of anti-cord factor (trehalose-6,6'-dimycolate) IgG antibody in rabbits recognizing mycolic acid subclasses of Mycobacterium tuberculosis or Mycobacterium avium.
    Fujiwara N; Pan J; Enomoto K; Terano Y; Honda T; Yano I
    FEMS Immunol Med Microbiol; 1999 Jun; 24(2):141-9. PubMed ID: 10378413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of mannophosphoinositides of mycobacteria: effect of cord factor (trehalose-6,6'-dimycolate).
    Mehta PK; Khuller GK
    Folia Microbiol (Praha); 1990; 35(6):570-7. PubMed ID: 1963168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Cross reactions between mycobacterial antigens.
    Rees RJ
    Ann Sclavo; 1971; 13(6):430-46. PubMed ID: 5005892
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of serologic and cell-mediated reactivity of a 38-kDa antigen isolated from Mycobacterium tuberculosis.
    Kadival GV; Chaparas SD; Hussong D
    J Immunol; 1987 Oct; 139(7):2447-51. PubMed ID: 2443566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of a monoclonal antibody (P6) reactive to Mycobacterium tuberculosis.
    Kapoor J; Batra HV; Gupta SK; Moudgil KD; Talwar GP
    Zentralbl Bakteriol; 1990 Sep; 273(4):545-54. PubMed ID: 1701087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isolation from romanian BCG substrain of non cross reacting antigens to Mycobacterium tuberculosis H37Rv strain.
    Niculescu D; Stavri D; Stavri H; Claiciu I; Bărbulescu R
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):213-9. PubMed ID: 6424629
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to sulpholipids of Mycobacterium tuberculosis H37 Rv.
    Mehta P; Khuller GK
    Indian J Med Res; 1987 Nov; 86():558-63. PubMed ID: 3132424
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody response to sulfolipids in experimental tuberculosis.
    Malik U; Khuller GK
    Antonie Van Leeuwenhoek; 1982; 48(3):285-8. PubMed ID: 6812498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG.
    Minden P; Kelleher PJ; Freed JH; Nielsen LD; Brennan PJ; McPheron L; McClatchy JK
    Infect Immun; 1984 Nov; 46(2):519-25. PubMed ID: 6389346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens.
    Hiromatsu K; Dascher CC; LeClair KP; Sugita M; Furlong ST; Brenner MB; Porcelli SA
    J Immunol; 2002 Jul; 169(1):330-9. PubMed ID: 12077262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.
    Yarkoni E; Rapp HJ
    Infect Immun; 1980 Jun; 28(3):887-92. PubMed ID: 6995326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interaction of Mycobacteria isolated from sarcoidosis patients with antituberculosis antibodies].
    Litvinov VI; Chernousova LN; Safonova SG; Kalinina OA; Kulikovskaia NV; Kapina MA; Dem'ianenko NV
    Probl Tuberk; 1997; (5):36-8. PubMed ID: 9454251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed-type hypersensitivity to a recombinant mycobacterial antigen, MPB64, in guinea pigs sensitized to Mycobacterium tuberculosis or Mycobacterium bovis BCG.
    Haga S; Yamaguchi R; Nagai S; Matsuo K; Yamazaki A; Nakamura RM
    J Leukoc Biol; 1995 Feb; 57(2):221-5. PubMed ID: 7531745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPB70, a unique antigen of Mycobacterium bovis BCG.
    Harboe M; Nagai S
    Am Rev Respir Dis; 1984 Mar; 129(3):444-52. PubMed ID: 6367574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis.
    Feng CG; Palendira U; Demangel C; Spratt JM; Malin AS; Britton WJ
    Infect Immun; 2001 Jun; 69(6):4174-6. PubMed ID: 11349095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.